Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.256
https://www.valueinhealthjournal.com/article/S1098-3015(17)30590-9/fulltext
Title : Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30590-9&doi=10.1016/j.jval.2017.08.256
First page : A443
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 234
Categories :
Tags :
Regions :
ViH Article Tags :